Cramlington, NE23 3JL,
United Kingdom
Aesica Pharmaceuticals Technographics
Aesica Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Aesica Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 212 Aesica Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Aesica Pharmaceuticals has purchased the following applications: Microsoft 365 for Collaboration in 2019, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Aesica Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Microsoft , Exclaimer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Aesica Pharmaceuticals revenues, which have grown to $36.1 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aesica Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Aesica Pharmaceuticals Tech Stack and Enterprise Applications
Aesica Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2019 | 2019 |
In 2019, Aesica Pharmaceuticals deployed Microsoft 365 as its Collaboration platform. Public references on the company's website indicate Microsoft 365 is used on their website, confirming organization-level adoption. The implementation leverages standard Collaboration capabilities such as Exchange Online mail, SharePoint Online content collaboration, Microsoft Teams messaging and meetings, and Office productivity applications.
The deployment is structured as a cloud tenant with centralized administration and organization-wide provisioning, applying identity and access controls across corporate, quality, manufacturing, and R&D functions. Governance for a life sciences environment of this scale emphasizes information governance, retention policies, and role-based access controls implemented through Microsoft 365 configuration. Microsoft 365 supports document management, internal communications, and cross-functional collaboration across Aesica Pharmaceuticals.
|
Aesica Pharmaceuticals Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2019 | 2019 |
In 2019, Aesica Pharmaceuticals deployed Exclaimer Cloud Signatures for Office 365 to centralize corporate email signature management. The deployment is categorized as Digital Signing and is observable via Aesica's public site markup indicating Exclaimer usage.
The implementation of Exclaimer Cloud Signatures for Office 365 was configured to provide centralized template and policy management, server side signature injection for Office 365 mail flow, and dynamic personalization using Office 365 directory attributes. Functional capabilities implemented include template versioning, role based administration for signature control, and policy rules to apply different signatures by department or user attribute.
Integration scope centers on Office 365, with signature application tied into the organization's mail routing and directory data. Operational coverage focused on corporate email communications and branding, affecting marketing, corporate communications, and IT operations responsible for policy enforcement and signature lifecycle.
Governance was organized around centralized administration and template approval workflows, enabling consistent branding and controlled updates to signature assets. The narrative reflects an application level implementation of Exclaimer Cloud Signatures for Office 365 within Aesica Pharmaceuticals, aligned to the Digital Signing category and integrated into Office 365 mail and directory services.
|
IT Decision Makers and Key Stakeholders at Aesica Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Aesica Pharmaceuticals Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||